KR970707125A - 염증성 장 질환 치료용의 5-아미노살리실산의아조 유도체(azo derivatives of 5-aminosalicylic acid for treatment of inflammatory bowel-disease) - Google Patents
염증성 장 질환 치료용의 5-아미노살리실산의아조 유도체(azo derivatives of 5-aminosalicylic acid for treatment of inflammatory bowel-disease)Info
- Publication number
- KR970707125A KR970707125A KR1019970703002A KR19970703002A KR970707125A KR 970707125 A KR970707125 A KR 970707125A KR 1019970703002 A KR1019970703002 A KR 1019970703002A KR 19970703002 A KR19970703002 A KR 19970703002A KR 970707125 A KR970707125 A KR 970707125A
- Authority
- KR
- South Korea
- Prior art keywords
- treatment
- inflammatory bowel
- disease
- aminosalicylic acid
- azo derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES9501752 | 1995-09-08 | ||
ES9501752A ES2106682B1 (es) | 1995-09-08 | 1995-09-08 | Nuevos derivados azo del acido 5-aminosalicilico. |
ES9501967A ES2104513B1 (es) | 1995-10-11 | 1995-10-11 | Nuevos derivados del acido 5-aminosalicilico. |
ES9501967 | 1995-10-11 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR970707125A true KR970707125A (ko) | 1997-12-01 |
KR100481300B1 KR100481300B1 (ko) | 2005-07-29 |
Family
ID=26154915
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019970703002A KR100481300B1 (ko) | 1995-09-08 | 1996-09-06 | 염증성장질환치료용의5-아미노살리실산의아조유도체 |
Country Status (17)
Country | Link |
---|---|
US (1) | US5747477A (ko) |
EP (1) | EP0790998B1 (ko) |
JP (1) | JP4115522B2 (ko) |
KR (1) | KR100481300B1 (ko) |
AR (1) | AR004198A1 (ko) |
AT (1) | ATE198751T1 (ko) |
AU (1) | AU6987596A (ko) |
BR (1) | BR9606628A (ko) |
CA (1) | CA2204747C (ko) |
DE (1) | DE69611598T2 (ko) |
DK (1) | DK0790998T3 (ko) |
ES (1) | ES2155621T3 (ko) |
GR (1) | GR3035622T3 (ko) |
MX (1) | MX9702919A (ko) |
NO (1) | NO308850B1 (ko) |
PT (1) | PT790998E (ko) |
WO (1) | WO1997009329A1 (ko) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6958324B2 (en) * | 1998-12-02 | 2005-10-25 | Inotek Pharmaceuticals Corporation | Inosine compounds and their use for treating or preventing an inflamation or a reperfusion disease |
ES2165803B1 (es) | 2000-04-10 | 2003-09-16 | Uriach & Cia Sa J | Nueva sal de un derivado azo del acido 5-aminosalicilico |
WO2001098268A2 (en) | 2000-06-21 | 2001-12-27 | Bristol-Myers Squibb Pharma Company | Piperidine amides as modulators of chemokine receptor activity |
JP4163946B2 (ja) * | 2000-08-29 | 2008-10-08 | バイオコン・リミテッド | 免疫調節性化合物およびその誘導体並びにそれを用いて疾患を治療する方法 |
US8048924B2 (en) * | 2001-08-29 | 2011-11-01 | Biocon Limited | Methods and compositions employing 4-aminophenylacetic acid compounds |
US20030119792A1 (en) * | 2001-09-28 | 2003-06-26 | Roca Manuel Merlos | Method of inhibiting the production and/or effects of intestinal pro-inflammatory cytokines, prostaglandins and others |
ES2565848T3 (es) | 2004-07-07 | 2016-04-07 | Biocon Limited | Síntesis de compuestos inmunorreguladores unidos por grupos azoicos |
WO2006125293A1 (en) * | 2005-05-27 | 2006-11-30 | Antibe Therapeutics Inc. | Derivatives of 4- or 5-aminosalicylic acid |
US7498355B2 (en) | 2005-05-27 | 2009-03-03 | Antibe Therapeutics Inc. | Derivatives of 4- or 5-aminosalicylic acid |
US7741359B2 (en) | 2005-05-27 | 2010-06-22 | Antibe Therapeutics Inc. | Hydrogen sulfide derivatives of non-steroidal anti-inflammatory drugs |
CA2653869A1 (en) | 2006-06-06 | 2007-12-13 | Antibe Therapeutics Inc. | Salts of trimebutine and n-desmethyl trimebutine |
US7645801B2 (en) * | 2007-01-29 | 2010-01-12 | Alaven Pharmaceutical Llc | Reduced irritant enema for treatment of inflammatory bowel disease (IBD) |
CN105566153B (zh) * | 2014-10-14 | 2019-05-31 | 中国医学科学院药物研究所 | 偶氮苯衍生物及其制法和药物组合物与用途 |
EP3837993A4 (en) | 2018-06-19 | 2022-04-20 | Coenbio Co., Ltd. | COMPOSITION FOR IMPROVING INTESTINAL FUNCTION WITH LEUCONOSTOC SP. STRAIN |
KR102173168B1 (ko) | 2018-06-19 | 2020-11-03 | 주식회사 엠디헬스케어 | 류코노스톡속 균주를 포함하는 장 기능 개선용 조성물 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2396145A (en) * | 1940-12-14 | 1946-03-05 | Pharmscia Ab | Heterocyclic sulphonamido azo compounds |
US4312806A (en) * | 1981-03-02 | 1982-01-26 | G. D. Searle & Co. | Method and compounds for treating inflammatory bowel disease |
PT98673B (pt) * | 1990-08-15 | 1999-01-29 | British Bio Technology | Processo para a preparacao de compostos que sao antagonistas do factor de activacao de plaquetas por exemplo derivados de benzimidazole e de seus intermediarios |
GB9202791D0 (en) * | 1992-02-11 | 1992-03-25 | British Bio Technology | Compounds |
ES2087038B1 (es) * | 1994-11-07 | 1997-03-16 | Uriach & Cia Sa J | Nuevas piperidinas con actividad antagonista del paf. |
-
1996
- 1996-09-06 US US08/836,125 patent/US5747477A/en not_active Expired - Lifetime
- 1996-09-06 BR BR9606628A patent/BR9606628A/pt not_active IP Right Cessation
- 1996-09-06 DE DE69611598T patent/DE69611598T2/de not_active Expired - Lifetime
- 1996-09-06 WO PCT/EP1996/003921 patent/WO1997009329A1/en not_active Application Discontinuation
- 1996-09-06 EP EP96931039A patent/EP0790998B1/en not_active Expired - Lifetime
- 1996-09-06 AR ARP960104275A patent/AR004198A1/es active IP Right Grant
- 1996-09-06 AU AU69875/96A patent/AU6987596A/en not_active Abandoned
- 1996-09-06 ES ES96931039T patent/ES2155621T3/es not_active Expired - Lifetime
- 1996-09-06 JP JP51087597A patent/JP4115522B2/ja not_active Expired - Fee Related
- 1996-09-06 MX MX9702919A patent/MX9702919A/es unknown
- 1996-09-06 KR KR1019970703002A patent/KR100481300B1/ko not_active IP Right Cessation
- 1996-09-06 AT AT96931039T patent/ATE198751T1/de active
- 1996-09-06 CA CA002204747A patent/CA2204747C/en not_active Expired - Fee Related
- 1996-09-06 DK DK96931039T patent/DK0790998T3/da active
- 1996-09-06 PT PT96931039T patent/PT790998E/pt unknown
-
1997
- 1997-05-07 NO NO972113A patent/NO308850B1/no not_active IP Right Cessation
-
2001
- 2001-03-23 GR GR20010400467T patent/GR3035622T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
KR100481300B1 (ko) | 2005-07-29 |
US5747477A (en) | 1998-05-05 |
AR004198A1 (es) | 1998-11-04 |
WO1997009329A1 (en) | 1997-03-13 |
CA2204747A1 (en) | 1997-03-13 |
MX9702919A (es) | 1998-04-30 |
NO972113D0 (no) | 1997-05-07 |
ES2155621T3 (es) | 2001-05-16 |
NO308850B1 (no) | 2000-11-06 |
CA2204747C (en) | 2009-05-05 |
DE69611598T2 (de) | 2001-06-07 |
DE69611598D1 (de) | 2001-02-22 |
ATE198751T1 (de) | 2001-02-15 |
GR3035622T3 (en) | 2001-06-29 |
JPH11501939A (ja) | 1999-02-16 |
EP0790998B1 (en) | 2001-01-17 |
EP0790998A1 (en) | 1997-08-27 |
AU6987596A (en) | 1997-03-27 |
DK0790998T3 (da) | 2001-02-05 |
JP4115522B2 (ja) | 2008-07-09 |
NO972113L (no) | 1997-05-07 |
BR9606628A (pt) | 1997-09-30 |
PT790998E (pt) | 2001-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9510256A (pt) | Derivados de ácido 3-aril-tetrônico | |
ATE211131T1 (de) | Arylsulfonylaminohydroxamsäurederivate | |
FI973002A (fi) | Terapeuttinen yhdiste - rasvahappokonjugaatit | |
NO950785D0 (no) | Fettsyrederivater | |
DK0730864T3 (da) | Lægemiddel til behandling af inflammatoriske hjertesygdomme | |
KR970707125A (ko) | 염증성 장 질환 치료용의 5-아미노살리실산의아조 유도체(azo derivatives of 5-aminosalicylic acid for treatment of inflammatory bowel-disease) | |
NO961006D0 (no) | Fosfonomononukleinsyrer, fremgangsmåter for fremstilling derav og anvendelse av forbindelsene | |
NO951165D0 (no) | Purinderivater og suppresjonspreparater for inflammasjons-sykdommer | |
KR970000230A (ko) | 염증성 장 질환을 치료하기 위한 캅파-아편제 작용물질 | |
AU642762B2 (en) | Method of treating inflammatory bowel disease | |
DE69606053D1 (de) | Modifizierte fluorsulfonsäure | |
GB9517043D0 (en) | The use of bile acid derivatives | |
DE69616554D1 (de) | Sialinsäure-derivate | |
NO993845D0 (no) | Fremgangsmåte for fremstilling av smörsyrederivater | |
BR9603916A (pt) | Derivados de ácido 2-(pirazolióxi-pirimidin-5-il) acético | |
NO982090L (no) | FremgangsmÕte for fremstilling av 3-fenyl-1-metylendioksyfenyl-indan-2-karboksylsyrederivater | |
AU9055091A (en) | Treatment for inflammatory bowel disease | |
NO991098D0 (no) | FremgangsmÕte for fremstilling av 2-fenyl-3-naftylpropionsyrederivater | |
NO924702L (no) | Pyridyl-benzosyrederivater for behandling av leukotrien-relaterte sykdommer | |
NO924701D0 (no) | Amid-bundete pyridyl-benzosyrederivater for behandling avleukotrien-relaterte sykdommer | |
KR970004262U (ko) | 질강 수축기 | |
DK14995A (da) | Fremgangsmåde til fremstilling af propionsyrederivater | |
IT1293464B1 (it) | Apparecchio elettromedicale per la cura di patologie infiammatorie acute | |
AUPO978597A0 (en) | Methods of treating inflammatory bowel disease | |
SE9504349D0 (sv) | New amino acid derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
AMND | Amendment | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
AMND | Amendment | ||
J201 | Request for trial against refusal decision | ||
B90T | Transfer of trial file for re-examination | ||
B701 | Decision to grant | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20120224 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20130304 Year of fee payment: 9 |
|
LAPS | Lapse due to unpaid annual fee |